Age‐related macular degeneration—clinical review and genetics update

Abstract

Age-related macular degeneration (AMD) is the leading cause of central vision impairment in persons over the age of 50 years in developed countries. Both genetic and non-genetic (environmental) factors play major roles in AMD etiology, and multiple gene variants and lifestyle factors such as smoking have been associated with the disease. While dissecting the basic etiology of the disease remains a major challenge, current genetic knowledge has provided opportunities for improved risk assessment, molecular diagnosis and clinical testing of genetic variants in AMD treatment and management. This review addresses the potential of translating the wealth of genetic findings for improved risk prediction and therapeutic intervention in AMD patients. Finally, we discuss the recent advancement in genetics and genomics and the future prospective of personalized medicine in AMD patients.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 71

1. 1.

   Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704.

   Not in our library10.1016/s0161-6420(00)00580-7

2. 2.

   Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.

   Not in our library10.1001/archopht.122.4.564

3. 3.

   Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574.

   Not in our library10.1001/archopht.123.11.1570

4. 4.
   Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis · 2010

   No notice
5. 5.

   Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486-495.

   Not in our library10.1016/j.ajo.2003.11.069

6. 6.

   Klein R, Klein BE, Knudtson MD, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113:373-380.

   Not in our library10.1016/j.ophtha.2005.12.013

7. 7.

   Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533-539.

   Not in our library10.1016/j.ophtha.2004.10.047

8. 8.

   Munch IC, Linneberg A, Larsen M. Precursors of age-related macular degeneration: associations with physical activity, obesity and serum lipids in the Inter99 Eye Study. Invest Ophthalmol Vis Sci. 2013;54 (6):3932-3940.

   Not in our library10.1167/iovs.12-10785

9. 9.

   Kabasawa S, Mori K, Horie-Inoue K, et al. Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population. Ophthalmology. 2011;118:1082-1088.

   Not in our library10.1016/j.ophtha.2010.10.012

10. 10.

    Spencer KL, Olson LM, Schnetz-Boutaud N, et al. Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. PLoS One. 2011;6:e17784.

    Not in our library10.1371/journal.pone.0017784

11. 11.

    Iyengar SK, Song D, Klein BE, et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet. 2004;74:20-39.

    Not in our library10.1086/380912

12. 12.

    Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116:1082-1088.

    Not in our library10.1001/archopht.116.8.1082

13. 13.

    Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet. 2004;75:174-189.

    Not in our library10.1086/422476

14. 14.

    Abecasis GR, Yashar BM, Zhao Y, et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet. 2004;74:482-494.

    Not in our library10.1086/382786

15. 15.

    Edwards AO, Ritter R, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.

    Not in our library10.1126/science.1110189

16. 16.

    Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.

    Not in our library10.1126/science.1110359

17. 17.

    Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.

    Not in our library10.1126/science.1109557

18. 18.

    Zareparsi S, Branham KE, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet. 2005;77:149-153.

    Not in our library10.1086/431426

19. 19.

    Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet. 2006;38:1049-1054.

    Not in our library10.1038/ng1871

20. 20.

    Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200-1201.

    Not in our library10.1038/ng2131

21. 21.

    Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553-561.

    Not in our library10.1056/nejmoa072618

22. 22.

    Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458-462.

    Not in our library10.1038/ng1750

23. 23.

    Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100-104.

    Not in our library10.1038/ejhg.2008.140

24. 24.

    Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006;314:989-992.

    Not in our library10.1126/science.1133807

25. 25.

    Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227-3236.

    Not in our library10.1093/hmg/ddi353

26. 26.

    Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA. 2007;104:16227-16232.

    Not in our library10.1073/pnas.0703933104

27. 27.

    Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA. 2010;107:7401-7406.

    Not in our library10.1073/pnas.0912702107

28. 28.

    Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA. 2010;107:7395-7400.

    Not in our library10.1073/pnas.0912019107

29. 29.

    Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011;20:3699-3709.

    Not in our library10.1093/hmg/ddr270

30. 30.

    Arakawa S, Takahashi A, Ashikawa K, et al. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet. 2011;43:1001-1004.

    Not in our library10.1038/ng.938

31. 31.

    Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63:200-206.

    Not in our library10.1086/301901

32. 32.

    McKay GJ, Patterson CC, Chakravarthy U, et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat. 2011;32:1407-1416.

    Not in our library10.1002/humu.21577

33. 33.

    Zareparsi S, Reddick AC, Branham KE, et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci. 2004;45:1306-1310.

    Not in our library10.1167/iovs.03-1253

34. 34.

    Fritsche LG, Chen W, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433-439.

    Not in our library10.1038/ng.2578

35. 35.

    Gorin MB. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med. 2012;33:467-486.

    Not in our library10.1016/j.mam.2012.04.004

36. 36.

    Priya RR, Chew EY, Swaroop A. Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology. 2012;119:2526-2536.

    Not in our library10.1016/j.ophtha.2012.06.042

37. 37.

    Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet. 2009;10:19-43.

    Not in our library10.1146/annurev.genom.9.081307.164350

38. 38.

    A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.

    Not in our library10.1001/archopht.119.10.1417

39. 39.

    Chew EY, Clemons TE, Agron E, et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS Report No. 35. Ophthalmology. 2013.

    Not in our library10.1016/j.ophtha.2013.01.021

40. 40.

    SanGiovanni JP, Agron E, Clemons TE, Chew EY. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol. 2009;127:110-112.

    Not in our library10.1001/archophthalmol.2008.518

41. 41.

    Sangiovanni JP, Agron E, Meleth AD, et al. {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2009;90:1601-1607.

    Not in our library10.3945/ajcn.2009.27594

42. 42.

    SanGiovanni JP, Chew EY, Agron E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-1279.

    Not in our library10.1001/archopht.126.9.1274

43. 43.

    Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-2015.

    Not in our library10.1001/jama.2013.4997

44. 44.

    Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.

    Not in our library10.1016/s0002-9394(02)01624-0

45. 45.

    Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996;122:393-403.

    Not in our library10.1016/s0002-9394(14)72066-5

46. 46.

    Ho L, van Leeuwen R, Witteman JC, et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol. 2011;129:758-766.

    Not in our library10.1001/archophthalmol.2011.141

47. 47.

    Schaumberg DA, Hankinson SE, Guo Q, et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007;125:55-62.

    Not in our library10.1001/archopht.125.1.55

48. 48.
    Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers · 2009

    No notice
49. 49.

    Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BH. Modelling the genetic risk in age-related macular degeneration. PLoS One. 2012;7:e37979.

    Not in our library10.1371/journal.pone.0037979

50. 50.

    van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems. JAMA. 2005;293:1509-1513.

    Not in our library10.1001/jama.293.12.1509

51. 51.

    Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897-1908.

    Not in our library10.1056/nejmoa1102673

52. 52.

    Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.

    Not in our library10.1056/nejmoa054481

53. 53.

    Brantley MA, Fang AM, King JM, et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology. 2007;114:2168-2173.

    Not in our library10.1016/j.ophtha.2007.09.008

54. 54.

    Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol. 2009;93:610-613.

    Not in our library10.1136/bjo.2008.150995

55. 55.

    McKibbin M, Ali M, Bansal S, et al. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Br J Ophthalmol. 2012;96 (2):208.

    Not in our library10.1136/bjo.2010.193680

56. 56.

    Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115:1019-1025.

    Not in our library10.1016/j.ophtha.2008.01.036

57. 57.

    Gorin MB. A clinician's view of the molecular genetics of age-related maculopathy. Arch Ophthalmol. 2007;125:21-29.

    Not in our library10.1001/archopht.125.1.21

58. 58.

    Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.

    Not in our library10.1038/nature08494

59. 59.

    Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11:31-46.

    Not in our library10.1038/nrg2626

60. 60.

    Priya RR, Rajasimha HK, Brooks MJ, Swaroop A. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery. Methods Mol Biol. 2012;884:335-351.

    Not in our library10.1007/978-1-61779-848-1_24

61. 61.

    Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745-755.

    Not in our library10.1038/nrg3031

62. 62.

    Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2011;13:135-145.

    Not in our library10.1038/nrg3118

63. 63.

    Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008;40:695-701.

    Not in our library10.1038/ng.f.136

64. 64.

    Raychaudhuri S, Iartchouk O, Chin K, et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet. 2011;43:1232-1236.

    Not in our library10.1038/ng.976

65. 65.

    van de Ven JP, Nilsson SC, Tan PL, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet. 2013.

    Not in our library10.1038/ng.2640

66. 66.

    Do R, Kathiresan S, Abecasis GR. Exome sequencing and complex disease: practical aspects of rare variant association studies. Hum Mol Genet. 2012;21:R1-R9.

    Not in our library10.1093/hmg/dds387

67. 67.

    Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 1994;8:352-356.

    Not in our library10.1038/ng1294-352

68. 68.

    Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15:236-246.

    Not in our library10.1038/ng0397-236

69. 69.

    Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet. 2000;67:487-491.

    Not in our library10.1086/303018

70. 70.

    Abecasis GR, Auton A, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.

    Not in our library10.1038/nature11632

71. 71.

    Fu W, O'Connor TD, Jun G, et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013;493:216-220.

    Not in our library10.1038/nature11690

Cited by papers we hold 2

• Restoration of high-sensitivity and adapting vision with a cone opsin · 2019
  No notice
• Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.